Unveiling the Impact of Tumor-Infiltrating Lymphocytes (TILs) on Solid Tumors & the TCR Landscape

Time: 5:00 pm
day: DAY ONE TRACK 4 A

Details:

  • Exploring the potential of TILs as a groundbreaking avenue for cancer treatment by leveraging the body’s immune system to combat solid tumors
  • Understanding the pivotal role of TILs as prognostic indicators and their ability to infiltrate and target solid tumor microenvironments for therapeutic interventions
  • Delving into the diverse and specialized T-cell receptor (TCR) repertoires present within TILs and their critical role in orchestrating effective immune responses against various types of solid tumors

Speakers:

Stewart Abbot
Stewart Abbot